Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD

P. Montuschi, D. Paris, D. Melck, S. Valente, N. Mores, A. Trové, C. Mondino, L. Fuso, G. Santini, F. Macagno, M. Sofia, A. Motta (Rome, Pozzuoli (Naples), Naples, Italy)

Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Session: Assessment of airway inflammation by exhaled gases
Session type: Poster Discussion
Number: 3559
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Montuschi, D. Paris, D. Melck, S. Valente, N. Mores, A. Trové, C. Mondino, L. Fuso, G. Santini, F. Macagno, M. Sofia, A. Motta (Rome, Pozzuoli (Naples), Naples, Italy). Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD. Eur Respir J 2013; 42: Suppl. 57, 3559

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Decreased levels of bis-S-bimane in exhaled breath condensate of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015


Exhaled breath condensate hydrogen peroxide in obstructive airways disease
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Usefulness of exhaled breath condensate as non-invasive method of evaluating of biomarkers in severe asthma patients
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014


Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study
Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017
Year: 2018



Exhaled breath condensate pH in assessment of childhood asthma control
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014

Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008



Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Exacerbations after stepping down medication in children with well-controlled asthma: predictive value of spirometry and nitrite/nitrate concentration and pH in exhaled breath condensate
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Unbiased clustering of severe asthma patients based on exhaled breath profiles
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Exhaled breath analysis for identifying eosinophilic and neutrophilic inflammation in a mixed population of patients with asthma or COPD
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Hydrogen sulphide as a biomarker in COPD and asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Exhaled breath condensate pH identifies children with preschool asthma
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013


The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers
Source: International Congress 2016 – Molecular pathways of smoking-induced diseases
Year: 2016


Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008


Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010


Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

Early detection of patients with asthma or chronic bronchitis by investigation on exhaled air condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 275s
Year: 2002

Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014